Human Cytochrome P450 and Personalized Medicine

被引：8

作者：

Chen, Qi ^{[1
]}

Wei, Dongqing ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China

来源：

ADVANCE IN STRUCTURAL BIOINFORMATICS | 2015年 / 827卷

关键词：

Personalized medicine; SNPs; CYP450; SINGLE NUCLEOTIDE POLYMORPHISMS; CONGENITAL ADRENAL-HYPERPLASIA; DRUG; DISCOVERY; PHARMACOGENETICS; SCHIZOPHRENIA; WARFARIN; GENE;

D O I：

10.1007/978-94-017-9245-5_20

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Personalized medicine has become a hot topic ascribed to the development of Human Genome Project. And currently, bioinformatics methodology plays an essential role in personal drug design. Here in this review we mainly focused on the basic introduction of the SNPs of human drug metabolic enzymes and their relationships with personalized medicine. Some common bioinformatics analysis methods and latest progresses and applications in personal drug design have also been discussed. Thus bioinformatics studies on SNPs of human CYP450 genes will contribute to indicate the most possible genes that are associated with human diseases and relevant therapeutic targets, identify and predict the drug efficacy and adverse drug response, investigate individual gene specific properties and then provide personalized and optimal clinic therapies.

引用

页码：341 / 351

页数：11

共 45 条

[1] Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Arranz, M. J.
de Leon, J.
[J]. MOLECULAR PSYCHIATRY, 2007, 12 (08) : 707 - 747
[2] Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
Arranz, Maria J.
Kapur, Shitij
[J]. SCHIZOPHRENIA BULLETIN, 2008, 34 (06) : 1130 - 1144
[3] The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999
Bairoch, A
Apweiler, R
[J]. NUCLEIC ACIDS RESEARCH, 1999, 27 (01) : 49 - 54
[4] The Protein Data Bank
Berman, HM
Westbrook, J
Feng, Z
Gilliland, G
Bhat, TN
Weissig, H
Shindyalov, IN
Bourne, PE
[J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
[5] CYP2D6*4, CYP3A5*3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people
Blonk, Maren I.
van der Velde, Nathalie
van den Bemt, Patricia M. L. A.
van Schaik, Ron H. N.
van der Cammen, Tischa J. M.
[J]. PHARMACY WORLD & SCIENCE, 2010, 32 (01): : 26 - 29
[6] CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
Bradford, LD
[J]. PHARMACOGENOMICS, 2002, 3 (02) : 229 - 243
[7] Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: Current and developing technologies
Chorley, Brian N.
Wang, Xuting
Campbell, Michelle R.
Pittman, Gary S.
Noureddine, Maher A.
Bell, Douglas A.
[J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2008, 659 (1-2) : 147 - 157
[8] Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations
Concolino, Paola
Mello, Enrica
Zuppi, Cecilia
Capoluongo, Ettore
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (08) : 1057 - 1062
[9] Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs
Crivori, P.
Poggesi, I.
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (07) : 795 - 808
[10] Cytochrome P450 in silico: An integrative modeling approach
de Graaf, C
Vermeulen, NPE
Feenstra, KA
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) : 2725 - 2755

← 1 2 3 4 5 →